Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lemann

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|May 7, 1988
[Home parenteral nutrition for adults. Results of a multicenter survey in France]B Messing, P Landais, B Goldfarb, et al.
La Revue De Medecine Interne|March 6, 2002
[Unusual association: hepatic peliosis and Crohn's disease]D Launay, P Y Hatron, V Queyrel, et al.
Pathologie-Biologie|April 9, 2008
IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigationJ-L Herrmann, N Simonney, A Bergeron, et al.
Alimentary Pharmacology & Therapeutics|July 19, 2003
Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre studyJ-M Gornet, S Couve, Z Hassani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonistsF Tubach, P Ravaud, D Salmon-Céron, et al.
Annals of the Rheumatic Diseases|October 16, 2009
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registryX Mariette, F Tubach, H Bagheri, et al.
The American Journal of Gastroenterology|January 29, 2009
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiébaut, S Kotti, C Jung, et al.
Annals of the Rheumatic Diseases|December 24, 2010
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registryD Salmon-Ceron, F Tubach, O Lortholary, et al.
Inflammatory Bowel Diseases|July 21, 2010
RIP2 polymorphisms in inflammatory bowel diseasesR Thiébaut, V Douchin, C Jung, et al.
Gut|May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineG Vernier-Massouille, J Cosnes, M Lemann, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|May 7, 1988
[Home parenteral nutrition for adults. Results of a multicenter survey in France]B Messing, P Landais, B Goldfarb, et al.
La Revue De Medecine Interne|March 6, 2002
[Unusual association: hepatic peliosis and Crohn's disease]D Launay, P Y Hatron, V Queyrel, et al.
Pathologie-Biologie|April 9, 2008
IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigationJ-L Herrmann, N Simonney, A Bergeron, et al.
Alimentary Pharmacology & Therapeutics|July 19, 2003
Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre studyJ-M Gornet, S Couve, Z Hassani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonistsF Tubach, P Ravaud, D Salmon-Céron, et al.
Annals of the Rheumatic Diseases|October 16, 2009
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registryX Mariette, F Tubach, H Bagheri, et al.
The American Journal of Gastroenterology|January 29, 2009
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiébaut, S Kotti, C Jung, et al.
Annals of the Rheumatic Diseases|December 24, 2010
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registryD Salmon-Ceron, F Tubach, O Lortholary, et al.
Inflammatory Bowel Diseases|July 21, 2010
RIP2 polymorphisms in inflammatory bowel diseasesR Thiébaut, V Douchin, C Jung, et al.
Gut|May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineG Vernier-Massouille, J Cosnes, M Lemann, et al.
Pageof 5